b-1 In the area m<l, they are potentiative.
b -2 In the area m> 1, they are antagonistic.
In the study of the drug-receptor interaction, the analysis of the mode of drug antagonism had been the objects of the principal interests, and the drug-synergism had only been remarked in passing (1). Veldstra (2) mentioned the relation between drug receptor and synergism in his extensive review on "Synergism and Potentiation". A fine definition of synergism and antagonism was proposed by Gaddum as follows.
Figure 1 is some modification of that shown in his textbook. In the abscissa a multiple "m" of the effective concetration of the drug A and in the ordinate a multiple "n"
of that of the drug B is shown. The synergistic effect is divided into the following manner :
pharmacological action and the same site of action, are used in combination, they are additive, and that, when the two drugs have different sites of action, they are super additive.
These phenomena could be elucidated by the application of mass action law to the interaction of drug-receptor combination, in a similar way as drug antagonism.
As indicated in the title of this paper, our aim is to study precisely the relation between synergism and receptor theory by using isolated organs.
METHODS
Ileum segments isolated from guinea pigs (350 to 600 g in body weight) or mice (15 to 20 g), and suspended in Tyrode solution at 26°C were used as a test organ, ac cording to the previous report (3) . All data were shown on the average of 10 or more experiments and conclusion from the data were established at 95% probability level.
Dissociation constant K,, of an agonist was estimated as the concentration of the agonist to contract to 50% of the maximum response, which was obtained by interpolation from the contraction of two doses of the agonist concerned, that is, one dose produced a con traction more than 50% but less than 80% and another dose a contraction smaller than 50% but more than 20%. Then dissociation constant KB of competitive antagonist was estimated as follows. A concentration-action curve of the agonist with a definite con centration of the antagonist was obtained by using two doses of the agonist. the agonist to the half, two doses of the antagonist concerned were used, one of which inhibited a contraction more than 50% and another inhibited less than 50%. After these dissociation constants were obtained, all the experiments which would be mentioned in this paper were done with the same organ that was used for the estimation of the dis sociation constants in order to test our assumption precisely. The slope of the equations shown in this paper was 1 for ACh, histamine and their competitive inhibitors, but ~' is an effect on the maximum response of the drug combination. In the first experi ment shown in Fig. 2 histamine receptor, but the result obtained by the above experiment of synergism sup ports more strongly the assumption of a common receptor between histamine, diphen hydramine and atropine.
In the next experiment shown in Fig. 5 , a strange fact is shown that the combined use of two competitive antagonists questions the existence of a common receptor.
Hydrogen ion (H") inhibits ACh contraction competitively, but when it is applied in combination with atropine the combined effect is superadditive. In Fig. 6 "a" is a contraction curve of ACh at pH 7.4, "b" is that at pH 5.6 and "c" is a curve with atropine at pH 7.4, "d" is obtained in the presence of atropine at pH 5.6. This effect is superadditive in comparison with the curve "e", which is calculated from the equa tion (vii) on the assumption that hydrogen ion and atropine have a common receptor.
Therefore the action of hydrogen ion can not be limited on ACh receptorr as mention ed previously (6). Atropine and epinephrine each inhibits ACh contraction competitively as curve "b"
or "c" (Fig. 6 ). But when they are used in combination, the effect is superadditive as As we had reported in our previous paper (7), the so-called papaverine-like anti spasmodics are divided into two groups : to the first group belong strong basic substances such as benactyzine and other synthetic antispasmodics, which are called specific anta gonists, and to the second group belong weak bases such as papaverine and neutral substances as isoamyl esters, which are considered to act through their physicochemical property and are called nonspecific antagonists.
As such property will be exhibited even when the drug molecules are dissolved or diffused into the biophase, where the drug is supposed to act, the drug molecules could have no special site of action in the biophase.
To the contrary the specific paraverine-like antispasmodics has been reported to have their special site of action, which is supposed to be anionic, that is, the barium receptor. Now let us consider the combined effect of such two papaverine-like anti spasmodics.
From the above interpretation it is concluded that (a) the combined effect of two of the specific antispasmodics should be additive, (b) the combined effect of a specific antispasmodic and of a nonspecific antispasmodic should be potentiative, and that (c) two nonspecific antispasmodics should be potentiative, because the latter two dissolve independently into the bio phase, In Table 1 inhibit the enzymatic decomposition of the drugs and elevate the concentration of the active drug. Such relationship is widely known between anticholinesterase and acetyl choline and between monoamine oxidase inhibitor and some catecholamines. Eserine sensitizes not only the action of ACh but also that of butyltrimethyl ammonium iodide (Fig. 7) , histamine and BaC12 (Fig. 8 ) which can not be decomposed by cholinesterase.
Cohen et al. (9) found that anticholinesterase potentiated decamethionium and choline which can not be decomposed by cholinesterase.
Potassium chloride sensitizes the action of ACh, histamine and BaC12, when the concentration of KCI is double the normal Tyrode solution (Fig. 9) . It is very interest ing that the maximum contraction increases by KC1. Fig. 10 indicates that eserine and potassium chloride antagonize more markedly to the specific antispasmodics than to paraverine. This fact also indicates the difference of the two kinds of papaverine-like antispasmodics.
CONCLUSION AND SUMMARY
The experimental results on synergism and sensitization were shown in this text and it was concluded that the drug synergism and sensitization are of great value for differentiation of the drug receptor, when they are considered in addition to the drug antagonism.
